Bordeaux, France

Jean-Pierre Collaueri

This inventor holds 1 USPTO granted patent. Top assignee: Rhodia Chimie. Active years: 2001.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Jean-Pierre Collaueri

Introduction

Jean-Pierre Collaueri is a notable inventor based in Bordeaux, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of sustained-release tablet formulations. His work has the potential to enhance the effectiveness of various medications.

Latest Patents

Collaueri holds a patent for "Pharmaceutical compositions in the form of sustained-release tablets based on high molecular weight polysaccharide granules." This invention relates to a delayed-release pharmaceutical composition that consists of at least one active principle and a matrix that provides the delayed-release effect. The matrix is characterized by its composition, which includes pregranulated polysaccharides of high molecular weight, derived from either synthetic or natural sources.

Career Highlights

Collaueri is associated with Rhodia Chimie, a company known for its innovative chemical solutions. His work at Rhodia Chimie has allowed him to focus on developing advanced pharmaceutical formulations that can improve patient outcomes.

Collaborations

Throughout his career, Collaueri has collaborated with several professionals in the field, including Guillaume Conrath and Paul-Joël Derian. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Jean-Pierre Collaueri's contributions to pharmaceutical innovations demonstrate his commitment to improving medication delivery systems. His patent for sustained-release tablets showcases the importance of research in enhancing therapeutic efficacy.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…